Connection

Jim Oates to Lupus Nephritis

This is a "connection" page, showing publications Jim Oates has written about Lupus Nephritis.
Connection Strength

5.484
  1. Endothelial cells: potential novel regulators of renal inflammation. Am J Physiol Renal Physiol. 2022 03 01; 322(3):F309-F321.
    View in: PubMed
    Score: 0.691
  2. Development of a lupus nephritis suboptimal response prediction tool using renal histopathological and clinical laboratory variables at the time of diagnosis. Lupus Sci Med. 2021 08; 8(1).
    View in: PubMed
    Score: 0.667
  3. Lupus serum induces inflammatory interaction with neutrophils in human glomerular endothelial cells. Lupus Sci Med. 2020 10; 7(1).
    View in: PubMed
    Score: 0.629
  4. Development of Biomarker Models to Predict Outcomes in Lupus Nephritis. Arthritis Rheumatol. 2016 08; 68(8):1955-63.
    View in: PubMed
    Score: 0.471
  5. NADPH oxidase and nitric oxide synthase-dependent superoxide production is increased in proliferative lupus nephritis. Lupus. 2013 Nov; 22(13):1361-70.
    View in: PubMed
    Score: 0.388
  6. Endothelial nitric oxide synthase reduces crescentic and necrotic glomerular lesions, reactive oxygen production, and MCP1 production in murine lupus nephritis. PLoS One. 2013; 8(5):e64650.
    View in: PubMed
    Score: 0.378
  7. Inhibition of sphingosine kinase-2 in a murine model of lupus nephritis. PLoS One. 2013; 8(1):e53521.
    View in: PubMed
    Score: 0.368
  8. Selective cyclooxygenase-2 inhibitor suppresses renal thromboxane production but not proliferative lesions in the MRL/lpr murine model of lupus nephritis. Am J Med Sci. 2011 Feb; 341(2):101-5.
    View in: PubMed
    Score: 0.322
  9. Association of serum nitrate and nitrite levels with longitudinal assessments of disease activity and damage in systemic lupus erythematosus and lupus nephritis. Arthritis Rheum. 2008 Jan; 58(1):263-72.
    View in: PubMed
    Score: 0.260
  10. Renal biopsy at the onset of clinical lupus nephritis: can it yield useful information? J Rheumatol. 2007 Feb; 34(2):256-8.
    View in: PubMed
    Score: 0.244
  11. Prediction of urinary protein markers in lupus nephritis. Kidney Int. 2005 Dec; 68(6):2588-92.
    View in: PubMed
    Score: 0.225
  12. Inducible nitric oxide synthase inhibitors reduce urinary markers of systemic oxidant stress in murine proliferative lupus nephritis. J Investig Med. 2005 Nov; 53(7):347-52.
    View in: PubMed
    Score: 0.224
  13. Prediction models of treatment response in lupus nephritis. Kidney Int. 2022 02; 101(2):379-389.
    View in: PubMed
    Score: 0.171
  14. Camptothecin and Topotecan, Inhibitors of Transcription Factor Fli-1 and Topoisomerase, Markedly Ameliorate Lupus Nephritis in (NZB ? NZW)F1 Mice and Reduce the Production of Inflammatory Mediators in Human Renal Cells. Arthritis Rheumatol. 2021 08; 73(8):1478-1488.
    View in: PubMed
    Score: 0.165
  15. Renal glycosphingolipid metabolism is dysfunctional in lupus nephritis. J Am Soc Nephrol. 2015 Jun; 26(6):1402-13.
    View in: PubMed
    Score: 0.104
  16. Inducible nitric oxide synthase inhibitor SD-3651 reduces proteinuria in MRL/lpr mice deficient in the NOS2 gene. J Investig Med. 2008 Oct; 56(7):911-9.
    View in: PubMed
    Score: 0.068
  17. Urine biomarkers predict the cause of glomerular disease. J Am Soc Nephrol. 2007 Mar; 18(3):913-22.
    View in: PubMed
    Score: 0.061
  18. Prospective measure of serum 3-nitrotyrosine levels in systemic lupus erythematosus: correlation with disease activity. Proc Assoc Am Physicians. 1999 Nov-Dec; 111(6):611-21.
    View in: PubMed
    Score: 0.037
  19. Leveraging of open EMR architecture for clinical trial accrual. AMIA Annu Symp Proc. 2003; 16-20.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.